ADMA BIOLOGICS, INC. Deferred Tax Assets, Deferred Income
ADMA BIOLOGICS, INC. (ADMA) had Deferred Tax Assets, Deferred Income of $434.00 thousand as of 2023-12-31, per its 10-K filed 2024-02-28.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsDeferredIncome · last filed 2024-02-28
- 2023-12-31: Deferred Tax Assets, Deferred Income $434.00K.
- 2022-12-31: Deferred Tax Assets, Deferred Income $480.00K; Deferred Tax Assets, Deferred Income as first filed $479.51K.
- 2021-12-31: Deferred Tax Assets, Deferred Income $519.82K.
- 2020-12-31: Deferred Tax Assets, Deferred Income $563.96K.
| Period end | Deferred Tax Assets, Deferred Income | Deferred Tax Assets, Deferred Income as first filed |
|---|---|---|
| 2023-12-31 | $434.00K 10-K · filed 2024-02-28 | |
| 2022-12-31 | $480.00K 10-K · filed 2024-02-28 | $479.51K 10-K · filed 2023-03-23 |
| 2021-12-31 | $519.82K 10-K · filed 2023-03-23 | |
| 2020-12-31 | $563.96K 10-K · filed 2022-03-24 | |
| 2019-12-31 | $603.53K 10-K · filed 2021-03-25 | |
| 2018-12-31 | $624.61K 10-K · filed 2020-03-13 | |
| 2017-12-31 | $679.07K 10-K · filed 2019-03-13 | |
| 2016-12-31 | $972.35K 10-K · filed 2018-03-29 | |
| 2015-12-31 | $1.02M 10-K · filed 2017-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |